We assessed the association between demographic and clinical variables ( particularly HbA1c ) and prevalent MVD at time of enrollment into the VA Diabetes Trial ( VADT ) , a 7-year randomized trial to determine whether intensive glycemic control will reduce risk of MVD events in older participants with established Type 2 diabetes .
